Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Research Report 2026(Status and Outlook)
Cell and Gene Therapy (CGT) drugs are a class of innovative treatments that treat diseases by changing the patient's cells or genes. Specifically, CGT drugs usually include: 1. Gene therapy: by introducing, deleting or repairing genes into the patient's cells, the purpose is to correct diseases caused by genetic defects or mutations. For example, gene therapy can deliver normal genes to patients through viral vectors to replace missing or defective genes.2. Cell therapy: by changing or enhancing the patient's own cells and then re-injecting them into the body for treatment. Common cell therapies include using immune cells (such as CAR-T cells) to treat cancer or using stem cells to repair damaged tissues.
The global Cell and Gene Therapy (CGT) Pharmaceuticals market size was estimated at USD 16710.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell and Gene Therapy (CGT) Pharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell and Gene Therapy (CGT) Pharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell and Gene Therapy (CGT) Pharmaceuticals market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy (CGT) Pharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell and Gene Therapy (CGT) Pharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Cell and Gene Therapy (CGT) Pharmaceuticals market size was estimated at USD 16710.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell and Gene Therapy (CGT) Pharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell and Gene Therapy (CGT) Pharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell and Gene Therapy (CGT) Pharmaceuticals market.
Global Cell and Gene Therapy (CGT) Pharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Vericel
- Castle Creek
- Terumo
- Nipro
- BioCardia
- Sanpower Group
- Novartis
- Gilead Sciences, Inc./Fosun Kite
- BMS
- JW (Cayman) Therapeutics
- Legend Biotech Corp./Johnson & Johnson
- Innovent Biologics, Inc./IASO Biotherapeutics
- Juventas/CASI
- CARsgen Therapeutics Holdings
- Huadong Medicine
- inno.N
- lovance
- Mesoblast
- Takeda
- Pierre fabre
- Aurion Biotech
- Gamida Cell
- CellTrans
- SiBiono Gene Technology
- Ferring
- Kyowa Kirin
- uniQure
- Roche
- PTC Therapeutics
- BioMarin
Market Segmentation (by Type)
- Cell Therapy Drugs
- Gene Therapy Drugs
Market Segmentation (by Application)
- Hospital
- Clinic
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell and Gene Therapy (CGT) Pharmaceuticals Market
Overview of the regional outlook of the Cell and Gene Therapy (CGT) Pharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy (CGT) Pharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell and Gene Therapy (CGT) Pharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy (CGT) Pharmaceuticals
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy (CGT) Pharmaceuticals Segment by Type
1.2.2 Cell and Gene Therapy (CGT) Pharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Product Life Cycle
3.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Cell and Gene Therapy (CGT) Pharmaceuticals Market Competitive Situation and Trends
3.8.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Cell and Gene Therapy (CGT) Pharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell and Gene Therapy (CGT) Pharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2020-2025)
6.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Price by Type (2020-2025)
7 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Growth Rate by Application (2020-2025)
8 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region
8.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.2.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country
8.3.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country
8.4.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.5.2 Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country
8.6.2 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.7.2 Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Cell and Gene Therapy (CGT) Pharmaceuticals by Region(2020-2025)
9.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell and Gene Therapy (CGT) Pharmaceuticals Production
9.4.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production
9.5.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production (2020-2025)
9.6.1 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell and Gene Therapy (CGT) Pharmaceuticals Production (2020-2025)
9.7.1 China Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Vericel
10.1.1 Vericel Basic Information
10.1.2 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.1.3 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.1.4 Vericel Business Overview
10.1.5 Vericel SWOT Analysis
10.1.6 Vericel Recent Developments
10.2 Castle Creek
10.2.1 Castle Creek Basic Information
10.2.2 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.2.3 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.2.4 Castle Creek Business Overview
10.2.5 Castle Creek SWOT Analysis
10.2.6 Castle Creek Recent Developments
10.3 Terumo
10.3.1 Terumo Basic Information
10.3.2 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.3.3 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.3.4 Terumo Business Overview
10.3.5 Terumo SWOT Analysis
10.3.6 Terumo Recent Developments
10.4 Nipro
10.4.1 Nipro Basic Information
10.4.2 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.4.3 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.4.4 Nipro Business Overview
10.4.5 Nipro Recent Developments
10.5 BioCardia
10.5.1 BioCardia Basic Information
10.5.2 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.5.3 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.5.4 BioCardia Business Overview
10.5.5 BioCardia Recent Developments
10.6 Sanpower Group
10.6.1 Sanpower Group Basic Information
10.6.2 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.6.3 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.6.4 Sanpower Group Business Overview
10.6.5 Sanpower Group Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.7.3 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Gilead Sciences, Inc./Fosun Kite
10.8.1 Gilead Sciences, Inc./Fosun Kite Basic Information
10.8.2 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.8.3 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.8.4 Gilead Sciences, Inc./Fosun Kite Business Overview
10.8.5 Gilead Sciences, Inc./Fosun Kite Recent Developments
10.9 BMS
10.9.1 BMS Basic Information
10.9.2 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.9.3 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.9.4 BMS Business Overview
10.9.5 BMS Recent Developments
10.10 JW (Cayman) Therapeutics
10.10.1 JW (Cayman) Therapeutics Basic Information
10.10.2 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.10.3 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.10.4 JW (Cayman) Therapeutics Business Overview
10.10.5 JW (Cayman) Therapeutics Recent Developments
10.11 Legend Biotech Corp./Johnson and Johnson
10.11.1 Legend Biotech Corp./Johnson and Johnson Basic Information
10.11.2 Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.11.3 Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.11.4 Legend Biotech Corp./Johnson and Johnson Business Overview
10.11.5 Legend Biotech Corp./Johnson and Johnson Recent Developments
10.12 Innovent Biologics, Inc./IASO Biotherapeutics
10.12.1 Innovent Biologics, Inc./IASO Biotherapeutics Basic Information
10.12.2 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.12.3 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.12.4 Innovent Biologics, Inc./IASO Biotherapeutics Business Overview
10.12.5 Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments
10.13 Juventas/CASI
10.13.1 Juventas/CASI Basic Information
10.13.2 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.13.3 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.13.4 Juventas/CASI Business Overview
10.13.5 Juventas/CASI Recent Developments
10.14 CARsgen Therapeutics Holdings
10.14.1 CARsgen Therapeutics Holdings Basic Information
10.14.2 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.14.3 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.14.4 CARsgen Therapeutics Holdings Business Overview
10.14.5 CARsgen Therapeutics Holdings Recent Developments
10.15 Huadong Medicine
10.15.1 Huadong Medicine Basic Information
10.15.2 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.15.3 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.15.4 Huadong Medicine Business Overview
10.15.5 Huadong Medicine Recent Developments
10.16 inno.N
10.16.1 inno.N Basic Information
10.16.2 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.16.3 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.16.4 inno.N Business Overview
10.16.5 inno.N Recent Developments
10.17 lovance
10.17.1 lovance Basic Information
10.17.2 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.17.3 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.17.4 lovance Business Overview
10.17.5 lovance Recent Developments
10.18 Mesoblast
10.18.1 Mesoblast Basic Information
10.18.2 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.18.3 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.18.4 Mesoblast Business Overview
10.18.5 Mesoblast Recent Developments
10.19 Takeda
10.19.1 Takeda Basic Information
10.19.2 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.19.3 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.19.4 Takeda Business Overview
10.19.5 Takeda Recent Developments
10.20 Pierre fabre
10.20.1 Pierre fabre Basic Information
10.20.2 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.20.3 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.20.4 Pierre fabre Business Overview
10.20.5 Pierre fabre Recent Developments
10.21 Aurion Biotech
10.21.1 Aurion Biotech Basic Information
10.21.2 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.21.3 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.21.4 Aurion Biotech Business Overview
10.21.5 Aurion Biotech Recent Developments
10.22 Gamida Cell
10.22.1 Gamida Cell Basic Information
10.22.2 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.22.3 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.22.4 Gamida Cell Business Overview
10.22.5 Gamida Cell Recent Developments
10.23 CellTrans
10.23.1 CellTrans Basic Information
10.23.2 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.23.3 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.23.4 CellTrans Business Overview
10.23.5 CellTrans Recent Developments
10.24 SiBiono Gene Technology
10.24.1 SiBiono Gene Technology Basic Information
10.24.2 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.24.3 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.24.4 SiBiono Gene Technology Business Overview
10.24.5 SiBiono Gene Technology Recent Developments
10.25 Ferring
10.25.1 Ferring Basic Information
10.25.2 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.25.3 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.25.4 Ferring Business Overview
10.25.5 Ferring Recent Developments
10.26 Kyowa Kirin
10.26.1 Kyowa Kirin Basic Information
10.26.2 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.26.3 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.26.4 Kyowa Kirin Business Overview
10.26.5 Kyowa Kirin Recent Developments
10.27 uniQure
10.27.1 uniQure Basic Information
10.27.2 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.27.3 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.27.4 uniQure Business Overview
10.27.5 uniQure Recent Developments
10.28 Roche
10.28.1 Roche Basic Information
10.28.2 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.28.3 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.28.4 Roche Business Overview
10.28.5 Roche Recent Developments
10.29 PTC Therapeutics
10.29.1 PTC Therapeutics Basic Information
10.29.2 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.29.3 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.29.4 PTC Therapeutics Business Overview
10.29.5 PTC Therapeutics Recent Developments
10.30 BioMarin
10.30.1 BioMarin Basic Information
10.30.2 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.30.3 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.30.4 BioMarin Business Overview
10.30.5 BioMarin Recent Developments
11 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast
11.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region
11.2.4 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell and Gene Therapy (CGT) Pharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2026-2035)
12.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2026-2035)
12.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) Forecast by Application
12.2.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy (CGT) Pharmaceuticals
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy (CGT) Pharmaceuticals Segment by Type
1.2.2 Cell and Gene Therapy (CGT) Pharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Product Life Cycle
3.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Cell and Gene Therapy (CGT) Pharmaceuticals Market Competitive Situation and Trends
3.8.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Cell and Gene Therapy (CGT) Pharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell and Gene Therapy (CGT) Pharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2020-2025)
6.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Price by Type (2020-2025)
7 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Growth Rate by Application (2020-2025)
8 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region
8.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.2.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country
8.3.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country
8.4.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.5.2 Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country
8.6.2 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region
8.7.2 Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Cell and Gene Therapy (CGT) Pharmaceuticals by Region(2020-2025)
9.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell and Gene Therapy (CGT) Pharmaceuticals Production
9.4.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production
9.5.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production (2020-2025)
9.6.1 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell and Gene Therapy (CGT) Pharmaceuticals Production (2020-2025)
9.7.1 China Cell and Gene Therapy (CGT) Pharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Cell and Gene Therapy (CGT) Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Vericel
10.1.1 Vericel Basic Information
10.1.2 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.1.3 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.1.4 Vericel Business Overview
10.1.5 Vericel SWOT Analysis
10.1.6 Vericel Recent Developments
10.2 Castle Creek
10.2.1 Castle Creek Basic Information
10.2.2 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.2.3 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.2.4 Castle Creek Business Overview
10.2.5 Castle Creek SWOT Analysis
10.2.6 Castle Creek Recent Developments
10.3 Terumo
10.3.1 Terumo Basic Information
10.3.2 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.3.3 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.3.4 Terumo Business Overview
10.3.5 Terumo SWOT Analysis
10.3.6 Terumo Recent Developments
10.4 Nipro
10.4.1 Nipro Basic Information
10.4.2 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.4.3 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.4.4 Nipro Business Overview
10.4.5 Nipro Recent Developments
10.5 BioCardia
10.5.1 BioCardia Basic Information
10.5.2 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.5.3 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.5.4 BioCardia Business Overview
10.5.5 BioCardia Recent Developments
10.6 Sanpower Group
10.6.1 Sanpower Group Basic Information
10.6.2 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.6.3 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.6.4 Sanpower Group Business Overview
10.6.5 Sanpower Group Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.7.3 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Gilead Sciences, Inc./Fosun Kite
10.8.1 Gilead Sciences, Inc./Fosun Kite Basic Information
10.8.2 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.8.3 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.8.4 Gilead Sciences, Inc./Fosun Kite Business Overview
10.8.5 Gilead Sciences, Inc./Fosun Kite Recent Developments
10.9 BMS
10.9.1 BMS Basic Information
10.9.2 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.9.3 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.9.4 BMS Business Overview
10.9.5 BMS Recent Developments
10.10 JW (Cayman) Therapeutics
10.10.1 JW (Cayman) Therapeutics Basic Information
10.10.2 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.10.3 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.10.4 JW (Cayman) Therapeutics Business Overview
10.10.5 JW (Cayman) Therapeutics Recent Developments
10.11 Legend Biotech Corp./Johnson and Johnson
10.11.1 Legend Biotech Corp./Johnson and Johnson Basic Information
10.11.2 Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.11.3 Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.11.4 Legend Biotech Corp./Johnson and Johnson Business Overview
10.11.5 Legend Biotech Corp./Johnson and Johnson Recent Developments
10.12 Innovent Biologics, Inc./IASO Biotherapeutics
10.12.1 Innovent Biologics, Inc./IASO Biotherapeutics Basic Information
10.12.2 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.12.3 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.12.4 Innovent Biologics, Inc./IASO Biotherapeutics Business Overview
10.12.5 Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments
10.13 Juventas/CASI
10.13.1 Juventas/CASI Basic Information
10.13.2 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.13.3 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.13.4 Juventas/CASI Business Overview
10.13.5 Juventas/CASI Recent Developments
10.14 CARsgen Therapeutics Holdings
10.14.1 CARsgen Therapeutics Holdings Basic Information
10.14.2 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.14.3 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.14.4 CARsgen Therapeutics Holdings Business Overview
10.14.5 CARsgen Therapeutics Holdings Recent Developments
10.15 Huadong Medicine
10.15.1 Huadong Medicine Basic Information
10.15.2 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.15.3 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.15.4 Huadong Medicine Business Overview
10.15.5 Huadong Medicine Recent Developments
10.16 inno.N
10.16.1 inno.N Basic Information
10.16.2 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.16.3 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.16.4 inno.N Business Overview
10.16.5 inno.N Recent Developments
10.17 lovance
10.17.1 lovance Basic Information
10.17.2 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.17.3 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.17.4 lovance Business Overview
10.17.5 lovance Recent Developments
10.18 Mesoblast
10.18.1 Mesoblast Basic Information
10.18.2 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.18.3 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.18.4 Mesoblast Business Overview
10.18.5 Mesoblast Recent Developments
10.19 Takeda
10.19.1 Takeda Basic Information
10.19.2 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.19.3 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.19.4 Takeda Business Overview
10.19.5 Takeda Recent Developments
10.20 Pierre fabre
10.20.1 Pierre fabre Basic Information
10.20.2 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.20.3 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.20.4 Pierre fabre Business Overview
10.20.5 Pierre fabre Recent Developments
10.21 Aurion Biotech
10.21.1 Aurion Biotech Basic Information
10.21.2 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.21.3 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.21.4 Aurion Biotech Business Overview
10.21.5 Aurion Biotech Recent Developments
10.22 Gamida Cell
10.22.1 Gamida Cell Basic Information
10.22.2 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.22.3 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.22.4 Gamida Cell Business Overview
10.22.5 Gamida Cell Recent Developments
10.23 CellTrans
10.23.1 CellTrans Basic Information
10.23.2 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.23.3 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.23.4 CellTrans Business Overview
10.23.5 CellTrans Recent Developments
10.24 SiBiono Gene Technology
10.24.1 SiBiono Gene Technology Basic Information
10.24.2 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.24.3 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.24.4 SiBiono Gene Technology Business Overview
10.24.5 SiBiono Gene Technology Recent Developments
10.25 Ferring
10.25.1 Ferring Basic Information
10.25.2 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.25.3 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.25.4 Ferring Business Overview
10.25.5 Ferring Recent Developments
10.26 Kyowa Kirin
10.26.1 Kyowa Kirin Basic Information
10.26.2 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.26.3 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.26.4 Kyowa Kirin Business Overview
10.26.5 Kyowa Kirin Recent Developments
10.27 uniQure
10.27.1 uniQure Basic Information
10.27.2 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.27.3 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.27.4 uniQure Business Overview
10.27.5 uniQure Recent Developments
10.28 Roche
10.28.1 Roche Basic Information
10.28.2 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.28.3 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.28.4 Roche Business Overview
10.28.5 Roche Recent Developments
10.29 PTC Therapeutics
10.29.1 PTC Therapeutics Basic Information
10.29.2 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.29.3 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.29.4 PTC Therapeutics Business Overview
10.29.5 PTC Therapeutics Recent Developments
10.30 BioMarin
10.30.1 BioMarin Basic Information
10.30.2 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
10.30.3 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Market Performance
10.30.4 BioMarin Business Overview
10.30.5 BioMarin Recent Developments
11 CELL AND GENE THERAPY (CGT) PHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast
11.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region
11.2.4 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell and Gene Therapy (CGT) Pharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2026-2035)
12.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2026-2035)
12.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) Forecast by Application
12.2.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (M USD)
Table 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application
Table 5. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals as of 2025)
Table 11. Global Market Cell and Gene Therapy (CGT) Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy (CGT) Pharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Type (K Units)
Table 27. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (M USD)
Table 28. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) by Type (2020-2025)
Table 29. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Cell and Gene Therapy (CGT) Pharmaceuticals Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) by Application
Table 34. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application
Table 35. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) by Region(2020-2025)
Table 55. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Vericel Basic Information
Table 63. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 64. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Vericel Business Overview
Table 66. Vericel SWOT Analysis
Table 67. Vericel Recent Developments
Table 68. Castle Creek Basic Information
Table 69. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 70. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Castle Creek Business Overview
Table 72. Castle Creek SWOT Analysis
Table 73. Castle Creek Recent Developments
Table 74. Terumo Basic Information
Table 75. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 76. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Terumo Business Overview
Table 78. Terumo SWOT Analysis
Table 79. Terumo Recent Developments
Table 80. Nipro Basic Information
Table 81. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 82. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Nipro Business Overview
Table 84. Nipro Recent Developments
Table 85. BioCardia Basic Information
Table 86. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 87. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. BioCardia Business Overview
Table 89. BioCardia Recent Developments
Table 90. Sanpower Group Basic Information
Table 91. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 92. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanpower Group Business Overview
Table 94. Sanpower Group Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 97. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. Gilead Sciences, Inc./Fosun Kite Basic Information
Table 101. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 102. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Gilead Sciences, Inc./Fosun Kite Business Overview
Table 104. Gilead Sciences, Inc./Fosun Kite Recent Developments
Table 105. BMS Basic Information
Table 106. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 107. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BMS Business Overview
Table 109. BMS Recent Developments
Table 110. JW (Cayman) Therapeutics Basic Information
Table 111. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 112. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. JW (Cayman) Therapeutics Business Overview
Table 114. JW (Cayman) Therapeutics Recent Developments
Table 115. Legend Biotech Corp./Johnson and Johnson Basic Information
Table 116. Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 117. Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Legend Biotech Corp./Johnson and Johnson Business Overview
Table 119. Legend Biotech Corp./Johnson and Johnson Recent Developments
Table 120. Innovent Biologics, Inc./IASO Biotherapeutics Basic Information
Table 121. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 122. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Innovent Biologics, Inc./IASO Biotherapeutics Business Overview
Table 124. Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments
Table 125. Juventas/CASI Basic Information
Table 126. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 127. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Juventas/CASI Business Overview
Table 129. Juventas/CASI Recent Developments
Table 130. CARsgen Therapeutics Holdings Basic Information
Table 131. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 132. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. CARsgen Therapeutics Holdings Business Overview
Table 134. CARsgen Therapeutics Holdings Recent Developments
Table 135. Huadong Medicine Basic Information
Table 136. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 137. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Huadong Medicine Business Overview
Table 139. Huadong Medicine Recent Developments
Table 140. inno.N Basic Information
Table 141. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 142. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. inno.N Business Overview
Table 144. inno.N Recent Developments
Table 145. lovance Basic Information
Table 146. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 147. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. lovance Business Overview
Table 149. lovance Recent Developments
Table 150. Mesoblast Basic Information
Table 151. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 152. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Mesoblast Business Overview
Table 154. Mesoblast Recent Developments
Table 155. Takeda Basic Information
Table 156. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 157. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Takeda Business Overview
Table 159. Takeda Recent Developments
Table 160. Pierre fabre Basic Information
Table 161. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 162. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Pierre fabre Business Overview
Table 164. Pierre fabre Recent Developments
Table 165. Aurion Biotech Basic Information
Table 166. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 167. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Aurion Biotech Business Overview
Table 169. Aurion Biotech Recent Developments
Table 170. Gamida Cell Basic Information
Table 171. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 172. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Gamida Cell Business Overview
Table 174. Gamida Cell Recent Developments
Table 175. CellTrans Basic Information
Table 176. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 177. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. CellTrans Business Overview
Table 179. CellTrans Recent Developments
Table 180. SiBiono Gene Technology Basic Information
Table 181. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 182. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. SiBiono Gene Technology Business Overview
Table 184. SiBiono Gene Technology Recent Developments
Table 185. Ferring Basic Information
Table 186. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 187. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Ferring Business Overview
Table 189. Ferring Recent Developments
Table 190. Kyowa Kirin Basic Information
Table 191. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 192. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Kyowa Kirin Business Overview
Table 194. Kyowa Kirin Recent Developments
Table 195. uniQure Basic Information
Table 196. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 197. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. uniQure Business Overview
Table 199. uniQure Recent Developments
Table 200. Roche Basic Information
Table 201. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 202. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 203. Roche Business Overview
Table 204. Roche Recent Developments
Table 205. PTC Therapeutics Basic Information
Table 206. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 207. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 208. PTC Therapeutics Business Overview
Table 209. PTC Therapeutics Recent Developments
Table 210. BioMarin Basic Information
Table 211. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 212. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 213. BioMarin Business Overview
Table 214. BioMarin Recent Developments
Table 215. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Region (2026-2035) & (K Units)
Table 216. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 217. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (K Units)
Table 218. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 219. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (K Units)
Table 220. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 221. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Region (2026-2035) & (K Units)
Table 222. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 223. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (K Units)
Table 224. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 225. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 226. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 227. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Type (2026-2035) & (K Units)
Table 228. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 229. Global Cell and Gene Therapy (CGT) Pharmaceuticals Price Forecast by Type (2026-2035) & (USD/Unit)
Table 230. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) Forecast by Application (2026-2035)
Table 231. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (M USD)
Table 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application
Table 5. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals as of 2025)
Table 11. Global Market Cell and Gene Therapy (CGT) Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy (CGT) Pharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Type (K Units)
Table 27. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (M USD)
Table 28. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) by Type (2020-2025)
Table 29. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Cell and Gene Therapy (CGT) Pharmaceuticals Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) by Application
Table 34. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application
Table 35. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) by Region(2020-2025)
Table 55. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Vericel Basic Information
Table 63. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 64. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Vericel Business Overview
Table 66. Vericel SWOT Analysis
Table 67. Vericel Recent Developments
Table 68. Castle Creek Basic Information
Table 69. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 70. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Castle Creek Business Overview
Table 72. Castle Creek SWOT Analysis
Table 73. Castle Creek Recent Developments
Table 74. Terumo Basic Information
Table 75. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 76. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Terumo Business Overview
Table 78. Terumo SWOT Analysis
Table 79. Terumo Recent Developments
Table 80. Nipro Basic Information
Table 81. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 82. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Nipro Business Overview
Table 84. Nipro Recent Developments
Table 85. BioCardia Basic Information
Table 86. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 87. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. BioCardia Business Overview
Table 89. BioCardia Recent Developments
Table 90. Sanpower Group Basic Information
Table 91. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 92. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanpower Group Business Overview
Table 94. Sanpower Group Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 97. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. Gilead Sciences, Inc./Fosun Kite Basic Information
Table 101. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 102. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Gilead Sciences, Inc./Fosun Kite Business Overview
Table 104. Gilead Sciences, Inc./Fosun Kite Recent Developments
Table 105. BMS Basic Information
Table 106. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 107. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BMS Business Overview
Table 109. BMS Recent Developments
Table 110. JW (Cayman) Therapeutics Basic Information
Table 111. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 112. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. JW (Cayman) Therapeutics Business Overview
Table 114. JW (Cayman) Therapeutics Recent Developments
Table 115. Legend Biotech Corp./Johnson and Johnson Basic Information
Table 116. Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 117. Legend Biotech Corp./Johnson and Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Legend Biotech Corp./Johnson and Johnson Business Overview
Table 119. Legend Biotech Corp./Johnson and Johnson Recent Developments
Table 120. Innovent Biologics, Inc./IASO Biotherapeutics Basic Information
Table 121. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 122. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Innovent Biologics, Inc./IASO Biotherapeutics Business Overview
Table 124. Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments
Table 125. Juventas/CASI Basic Information
Table 126. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 127. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Juventas/CASI Business Overview
Table 129. Juventas/CASI Recent Developments
Table 130. CARsgen Therapeutics Holdings Basic Information
Table 131. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 132. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. CARsgen Therapeutics Holdings Business Overview
Table 134. CARsgen Therapeutics Holdings Recent Developments
Table 135. Huadong Medicine Basic Information
Table 136. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 137. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Huadong Medicine Business Overview
Table 139. Huadong Medicine Recent Developments
Table 140. inno.N Basic Information
Table 141. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 142. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. inno.N Business Overview
Table 144. inno.N Recent Developments
Table 145. lovance Basic Information
Table 146. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 147. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. lovance Business Overview
Table 149. lovance Recent Developments
Table 150. Mesoblast Basic Information
Table 151. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 152. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Mesoblast Business Overview
Table 154. Mesoblast Recent Developments
Table 155. Takeda Basic Information
Table 156. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 157. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Takeda Business Overview
Table 159. Takeda Recent Developments
Table 160. Pierre fabre Basic Information
Table 161. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 162. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Pierre fabre Business Overview
Table 164. Pierre fabre Recent Developments
Table 165. Aurion Biotech Basic Information
Table 166. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 167. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Aurion Biotech Business Overview
Table 169. Aurion Biotech Recent Developments
Table 170. Gamida Cell Basic Information
Table 171. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 172. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Gamida Cell Business Overview
Table 174. Gamida Cell Recent Developments
Table 175. CellTrans Basic Information
Table 176. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 177. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. CellTrans Business Overview
Table 179. CellTrans Recent Developments
Table 180. SiBiono Gene Technology Basic Information
Table 181. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 182. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. SiBiono Gene Technology Business Overview
Table 184. SiBiono Gene Technology Recent Developments
Table 185. Ferring Basic Information
Table 186. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 187. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Ferring Business Overview
Table 189. Ferring Recent Developments
Table 190. Kyowa Kirin Basic Information
Table 191. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 192. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Kyowa Kirin Business Overview
Table 194. Kyowa Kirin Recent Developments
Table 195. uniQure Basic Information
Table 196. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 197. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. uniQure Business Overview
Table 199. uniQure Recent Developments
Table 200. Roche Basic Information
Table 201. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 202. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 203. Roche Business Overview
Table 204. Roche Recent Developments
Table 205. PTC Therapeutics Basic Information
Table 206. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 207. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 208. PTC Therapeutics Business Overview
Table 209. PTC Therapeutics Recent Developments
Table 210. BioMarin Basic Information
Table 211. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Overview
Table 212. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 213. BioMarin Business Overview
Table 214. BioMarin Recent Developments
Table 215. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Region (2026-2035) & (K Units)
Table 216. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 217. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (K Units)
Table 218. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 219. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (K Units)
Table 220. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 221. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Region (2026-2035) & (K Units)
Table 222. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 223. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (K Units)
Table 224. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 225. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 226. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 227. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Type (2026-2035) & (K Units)
Table 228. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 229. Global Cell and Gene Therapy (CGT) Pharmaceuticals Price Forecast by Type (2026-2035) & (USD/Unit)
Table 230. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) Forecast by Application (2026-2035)
Table 231. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell and Gene Therapy (CGT) Pharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell and Gene Therapy (CGT) Pharmaceuticals Product Life Cycle
Figure 13. Cell and Gene Therapy (CGT) Pharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell and Gene Therapy (CGT) Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy (CGT) Pharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Cell and Gene Therapy (CGT) Pharmaceuticals
Figure 19. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market PEST Analysis
Figure 20. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type in 2025
Figure 29. Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application
Figure 33. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application in 2025
Figure 37. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country in 2024
Figure 55. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region in 2024
Figure 68. China Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (K Units)
Figure 79. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell and Gene Therapy (CGT) Pharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cell and Gene Therapy (CGT) Pharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell and Gene Therapy (CGT) Pharmaceuticals Product Life Cycle
Figure 13. Cell and Gene Therapy (CGT) Pharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell and Gene Therapy (CGT) Pharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy (CGT) Pharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Cell and Gene Therapy (CGT) Pharmaceuticals
Figure 19. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market PEST Analysis
Figure 20. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type in 2025
Figure 29. Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application
Figure 33. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application in 2025
Figure 37. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country in 2024
Figure 55. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region in 2024
Figure 68. China Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (K Units)
Figure 79. South America Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell and Gene Therapy (CGT) Pharmaceuticals Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell and Gene Therapy (CGT) Pharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell and Gene Therapy (CGT) Pharmaceuticals Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell and Gene Therapy (CGT) Pharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Application (2026-2035)
